Feed HROW
HR

Harrow Health, Inc. HROW · NASDAQ

$27.68 +1.47% (+$0.40)

Market cap
$1.04B
Enterprise value
$1.25B
P/E
-
Forward P/E
-
PEG
-
P/S
3.8x
P/FCF
182.5x
EV/EBITDA
279.8x
ROIC
2.0%
Bruto marža
73.3%
Neto marža
-13.5%
Dividend yield
-
Payout ratio
-
Neto dolg/EBITDA
48.4x
Beta
0.24
Free float
77.2%

O podjetju

Harrow Health, Inc. is a pharmaceutical company primarily focused on providing affordable and innovative drugs and healthcare products. The company specializes in the development and commercialization of pharmaceuticals and medical devices in the fields of ophthalmology, dermatology, and neurology. Their portfolio includes a wide range of therapeutic products, including generics, branded drugs, and medical devices, aimed at treating various health conditions and diseases. Harrow Health, Inc. focuses on providing affordable and quality medications for patients and strengthening its position in the pharmaceuticals and healthcare products market.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Mark L. Baum

Employees

373

Headquarters

Nashville

Vrednotenje

Je današnja cena primerna?

Rast in ocene

Ali podjetje raste in kaj sledi?

Donosnost in kakovost

Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?

Finančno zdravje

Ali zmore svoj dolg?

Kapital in dividende

Kaj podjetje počne z zasluženim denarjem?

Analitiki

Kaj menijo strokovnjaki in ali se to spreminja?

Lastniki in insajderji

Kdo ima delnice in kaj počne vodstvo?

Segmenti

Kateri del podjetja raste?

Primerjava s konkurenco

Kako se primerja s podobnimi podjetji?

Cena in tveganje

Kako se delnica obnaša?

Izkazi

Vse številke

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.